4//SEC Filing
Rubinstein Linda M 4
Accession 0001415889-25-005835
CIK 0001501756other
Filed
Feb 26, 7:00 PM ET
Accepted
Feb 27, 4:05 PM ET
Size
8.4 KB
Accession
0001415889-25-005835
Insider Transaction Report
Form 4
Rubinstein Linda M
CHIEF FINANCIAL OFFICER
Transactions
- Award
Common Stock
2025-02-25+8,125→ 19,325 total - Award
Stock Option (Right to Buy)
2025-02-25+48,750→ 48,750 totalExercise: $4.20Exp: 2035-02-24→ Common Stock (48,750 underlying)
Footnotes (4)
- [F1]Represents shares of Common Stock issuable upon settlement of a restricted stock unit ("RSU") grant that will vest as to one-third (1/3rd) of the total number of shares subject to this award on each anniversary of March 1, 2025 (the "Vesting Commencement Date"), so that all of the shares subject to the RSUs are vested on the third (3rd) annual anniversary of the Vesting Commencement Date, subject to the Reporting Person's continued service with the Issuer on each vesting date.
- [F2]Includes 600 shares purchased on May 20, 2024 and 600 shares purchased on November 20, 2024, pursuant to the Issuer's 2014 Employee Stock Plan Purchase Plan, as amended and restated.
- [F3]On March 21, 2024, the Common Stock of Issuer split 1-for-10, resulting in a proportionate reduction of Reporting Person's shares.
- [F4]Twenty-five percent (25%) of the total number shares subject to the Option shall vest and become exercisable one year after the Vesting Commencement Date, and one-forty-eighth (1/48th) of the total number of shares subject to the Option shall vest and become exercisable each month thereafter, so that all of the shares subject to the Option are vested and exercisable on the fourth (4th) anniversary of the Vesting Commencement Date, subject to the Reporting Person's continued service with the Issuer on each vesting date.
Documents
Issuer
Adverum Biotechnologies, Inc.
CIK 0001501756
Entity typeother
Related Parties
1- filerCIK 0001321937
Filing Metadata
- Form type
- 4
- Filed
- Feb 26, 7:00 PM ET
- Accepted
- Feb 27, 4:05 PM ET
- Size
- 8.4 KB